AngioDynamics

Quarterly Financials

Values in thousands 2025-08-31 2025-05-31 2025-02-28 2024-11-30
Revenue
$75,711
$80,158
$72,004
$72,845
Gross Profit
41,857
42,218
38,857
39,906
EBITDA
-1,878
2,200
-329
1,793
EBIT
-7,898
-3,633
-6,648
-5,070
Net Income
-10,903
-6,050
-4,407
-10,738
Net Change In Cash
75,711
80,158
72,004
72,845
Free Cash Flow
-16,645
18,034
-14,957
1,676
Cash
38,762
55,893
44,760
54,089
Basic Shares
41,174
40,984
40,853
40,922

Annual Financials

Values in thousands 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Revenue
$292,498
$303,914
$338,752
$316,219
Gross Profit
157,705
154,698
174,246
165,732
EBITDA
1,738
-6,132
12,194
11,132
EBIT
-24,062
-33,844
-18,679
-18,217
Net Income
-33,993
-184,349
-52,442
-26,547
Net Change In Cash
292,498
303,914
338,752
316,219
Cost of Revenue
15,752
-18,818
Free Cash Flow
-14,592
-33,926
-4,274
-11,491
Cash
55,893
76,056
44,620
28,825
Basic Shares
40,984
40,180
39,480
39,009

Earnings Calls

Quarter EPS
2025-11-30
$0
2025-08-31
-$0.10
2025-05-31
-$0.03
2025-02-28
$0.03